Clinical Trials Sponsored by Robert Scott Harris, M.D.

Total 3 results

Robert Scott Harris, M.D.
Gilead Sciences

Withdrawn

FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan

Pulmonary Arterial Hypertension

United States
Robert L. Ferris, MD, PhD
Bristol-Myers Squibb

Recruiting

Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma (HNSCC)

United States
Robert L. Ferris, MD, PhD
Bristol-Myers Squibb

Active, not recruiting

Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer

Oropharynx Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck

United States

3

Subscribe